Abstract
Identification of CXCL13 as a Promising Biomarker for Immune Checkpoint Blockade Therapy and PARP Inhibitor Therapy in Ovarian Cancer
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
https://doi.org/10.1007/s12033-024-01207-5
Journal: Molecular Biotechnology | Publication Date: Jun 10, 2024 |
Identification of CXCL13 as a Promising Biomarker for Immune Checkpoint Blockade Therapy and PARP Inhibitor Therapy in Ovarian Cancer
Join us for a 30 min session where you can share your feedback and ask us any queries you have